Skip to navigation bar Skip to breadcrumbs Skip to page content
clear place holder Browse All Topics Envelope icon E-mail Updates Teal square Text size:  a A A

Depression in Children and Adolescents: Screening

Release Date: February 2016

Recommendation Summary

PopulationRecommendationGrade
(What's This?)
Adolescents aged 12 to 18 years

The USPSTF recommends screening for major depressive disorder (MDD) in adolescents aged 12 to 18 years. Screening should be implemented with adequate systems in place to ensure accurate diagnosis, effective treatment, and appropriate follow-up.

The USPSTF recommends the service. There is high certainty that the net benefit is moderate or there is moderate certainty that the net benefit is moderate to substantial.
Children aged 11 years or younger

The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for MDD in children aged 11 years or younger.

The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of the service. Evidence is lacking, of poor quality, or conflicting, and the balance of benefits and harms cannot be determined.

Related Information for Health Professionals

There is no related information for health professionals.

Clinical Summary

Clinical summaries are one-page documents that provide guidance to primary care clinicians for using recommendations in practice.

This summary is intended for use by primary care clinicians.

 
Current as of: September 2015

Internet Citation: Final Update Summary: Depression in Children and Adolescents: Screening. U.S. Preventive Services Task Force. September 2015.
http://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/depression-in-children-and-adolescents-screening1

USPSTF Program Office   5600 Fishers Lane, Mail Stop 06E53A, Rockville, MD 20857